This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
4A Galassi , K Reynolds & J He (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119, 812–819.
6I Rudkowska & PJ Jones (2007) Functional foods for the prevention and treatment of cardiovascular diseases: cholesterol and beyond. Expert Rev Cardiovasc Ther 5, 477–490.
7HG Shertzer , SE Woods , M Krishan , (2011) Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. J Nutr 141, 582–587.
8S Pal , V Ellis & S Ho (2010) Acute effects of whey protein isolate on cardiovascular risk factors in overweight, post-menopausal women. Atherosclerosis 212, 339–344.
10M Bortolotti , E Maiolo , M Corazza , (2011) Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin Nutr 30, 494–498.
12J Beaulieu , R Dubuc , N Beaudet , (2007) Immunomodulation by a malleable matrix composed of fermented whey proteins and lactic acid bacteria. J Med Food 10, 67–72.
13J Beaulieu , C Dupont & P Lemieux (2007) Anti-inflammatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria in an atopic dermatitis model. J Inflamm (Lond) 4, 6.
15J Beaulieu , E Millette , E Trottier , (2010) Regulatory function of a malleable protein matrix as a novel fermented whey product on features defining the metabolic syndrome. J Med Food 13, 509–519.
16HK Berthold , DM Schulte , JF Lapointe , (2011) The whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: a randomized placebo-controlled trial. J Dairy Sci 94, 589–601.
17SM Grundy , JI Cleeman , SR Daniels , (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752.
19AV Chobanian , GL Bakris , HR Black , (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560–2572.
20I Gouni-Berthold & W Krone (2005) Hypertriglyceridemia – why, when and how should it be treated? Z Kardiol 94, 731–739.
21SM Grundy , JI Cleeman , CN Merz , (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 24, e149–e161.
22SM Grundy (1999) Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 83, 25F–29F.
23H Bays (2008) Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians. Drugs Today (Barc) 44, 205–246.
24JW Anderson , BM Johnstone & ME Cook-Newell (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276–282.
25JW Anderson (2000) Dietary fiber prevents carbohydrate-induced hypertriglyceridemia. Curr Atheroscler Rep 2, 536–541.
26G AbouRjaili , N Shtaynberg , R Wetz , (2010) Current concepts in triglyceride metabolism, pathophysiology, and treatment. Metabolism 59, 1210–1220.
27LK Nies , AA Cymbala , SL Kasten , (2006) Complementary and alternative therapies for the management of dyslipidemia. Ann Pharmacother 40, 1984–1992.
28TJ Wang , P Gona , MG Larson , (2007) Multiple biomarkers and the risk of incident hypertension. Hypertension 49, 432–438.
29P Libby & J Plutzky (2007) Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol 99, 27B–40B.
31Q Chen & RA Reimer (2009) Dairy protein and leucine alter GLP-1 release and mRNA of genes involved in intestinal lipid metabolism in vitro. Nutrition 25, 340–349.
32S Nagaoka , Y Kanamaru , Y Kuzuya , (1992) Comparative studies on the serum cholesterol lowering action of whey protein and soybean protein in rats. Biosci Biotechnol Biochem 56, 1484–1485.
34DR Jacobs Jr, MD Gross & LC Tapsell (2009) Food synergy: an operational concept for understanding nutrition. Am J Clin Nutr 89, 1543S–1548S.
35S Nagaoka , Y Kanamaru & Y Kuzuya (1991) Effects of whey protein and casein on the plasma and liver lipids in rats. Agric Biol Chem 55, 813–818.
38M Kawase , H Hashimoto , M Hosoda , (2000) Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 83, 255–263.
41G Schaafsma , WJ Meuling , DW van , (1998) Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 52, 436–440.
43JZ Xiao , S Kondo , N Takahashi , (2003) Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86, 2452–2461.
44HM Lakka , DE Laaksonen , TA Lakka , (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709–2716.
45S Mottillo , KB Filion , J Genest , (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56, 1113–1132.
48SM Grundy , HB Brewer Jr, JI Cleeman , (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433–438.
49ES Ford , WH Giles & WH Dietz (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
50SM Grundy , JI Cleeman , SR Daniels , (2006) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21, 1–6.
51P Gaede , H Lund-Andersen , HH Parving , (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358, 580–591.
52M Coutinho , HC Gerstein , Y Wang , (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12·4 years. Diabetes Care 22, 233–240.
53SC Ho , YM Chen , JL Woo , (2001) Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes Relat Metab Disord 25, 1689–1697.
54A Onat , GS Avci , MM Barlan , (2004) Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord 28, 1018–1025.
56W Aekplakorn , V Kosulwat & P Suriyawongpaisal (2006) Obesity indices and cardiovascular risk factors in Thai adults. Int J Obes (Lond) 30, 1782–1790.
57DC Henderson , X Fan , B Sharma , (2009) Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract 15, 251–261.
58K Diepvens , D Haberer & M Westerterp-Plantenga (2008) Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans. Int J Obes (Lond) 32, 510–518.
59PW Wilson , WB Kannel , H Silbershatz , (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159, 1104–1109.
60Y Gerber , R Dankner , A Chetrit , (2005) The role of risk factor time trends in the steep decline of CHD mortality between two Israeli cohort studies. Prev Med 41, 85–91.
61B Angelin , B Leijd , R Hultcrantz , (1990) Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia. J Intern Med 227, 201–206.
62GC Major , JP Chaput , M Ledoux , (2008) Recent developments in calcium-related obesity research. Obes Rev 9, 428–445.
63HK Berthold , S Unverdorben , R Degenhardt , (2006) Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 295, 2262–2269.